Results 51 to 60 of about 10,947 (175)

Cost-effectiveness analysis of pharmaceutical treatment options in the first-line management of major depressive disorder in Belgium [PDF]

open access: yes, 2014
The objective of this study was to assess the cost effectiveness of commonly used antidepressants as first-line treatment of major depressive disorder (MDD) in Belgium.
Annemans, Lieven   +5 more
core   +2 more sources

Pharmacological treatment of depression in people with a primary brain tumour [PDF]

open access: yes, 2020
Background This is the second updated version of the Cochrane Review published in Issue 3, 2010 and first updated in Issue 5, 2013. People with a primary brain tumour oGen experience depression, for which drug treatment may be prescribed.
Beevers, Z   +3 more
core   +1 more source

Effect of Unrestricted Access to Running Wheels on Cancer-Related Fatigue [PDF]

open access: yes, 2011
Cancer-related fatigue (CRF) occurs in 60-90% of cancer patients and significantly reduces functional status. Tumor growth causes significant wasting of skeletal muscle, thought to be a major factor in CRF.
Little, Courtney
core  

Quality of life and cognitive function in patients with pituitary insufficiency [PDF]

open access: yes, 1998
This review is concerned with the psychosocial functioning and the quality of life in patients with pituitary insufficiency who are receiving conventional hormone replacement therapy.
Burman, P., Deijen, J.B.
core   +1 more source

COMORBIDITY OF DEPRESSIVE AND DERMATOLOGIC DISORDERS – THERAPEUTIC ASPECTS [PDF]

open access: yes, 2009
Depressive disorders are more common in the population affected with dermatologic disorders. Comorbidity of depression and dermatologic disorders is around 30%. The correlation between depressive and dermatologic disorders still remains unclear.
Anamarija Petek   +4 more
core   +1 more source

The Potent And Selective α4β2*/α6*-Nicotinic Acetylcholine Receptor Partial Agonist 2-[5-[5-((S)Azetidin-2-Ylmethoxy)-3-Pyridinyl]-3-Isoxazolyl]Ethanol Demonstrates Antidepressive-Like Behavior In Animal Models And A Favorable Adme-Tox Profile [PDF]

open access: yes, 2014
Preclinical and clinical studies demonstrated that the inhibition of cholinergic supersensitivity through nicotinic antagonists and partial agonists can be used successfully to treat depressed patients, especially those who are poor responders to ...
Brunner, Dani   +13 more
core   +2 more sources

Antidepressant use in late gestation and risk of postpartum haemorrhage: a retrospective cohort study [PDF]

open access: yes, 2015
Objective: To investigate the association between antidepressant use in late gestation and postpartum haemorrhage (PPH). Design: Retrospective cohort study. Tertiary teaching hospital in Adelaide, Australia. Population: A total of 30 198 women delivering
Clifton, V.   +3 more
core   +1 more source

Use of Desipramine for the Treatment of Overactive Bladder Refractory to Antimuscarinic Therapy [PDF]

open access: yes, 2013
Purpose: To evaluate the use of desipramine in the treatment of overactive bladder (OAB). Materials and Methods: We retrospectively evaluated 43 patients who were treated with desipramine for OAB refractory to antimuscarinic therapy.
Bagadiya, N.   +4 more
core   +2 more sources

SERTRALINE AND MIRTAZAPINE AS GERIATRIC ANTIDEPRESSANTS [PDF]

open access: yes, 2013
Background: Depression within the geriatric patient population is an important issue as it is associated with increased mortality. Such depression may have a different aetiology to that in younger patients and be associated with comorbid chronic physical
Bhogle, Madhavi, Holland, Jonathon
core   +1 more source

Home - About - Disclaimer - Privacy